LOXL2 and cancer: Besides, cancer patients with LOXL2 alternations of stable nuclear variant (SNV) had worse OS and PFS than those with no alterations in BRCA and CESC, while the copy number variation (CNV) of LOXL2 is associated with a worse prognosis in KIRP, UCEC, and BRCA (Fig. 3D, E).